"Global North America, Europe, and Australia Peanut Allergy Treatment Market Overview:
Global North America, Europe, and Australia Peanut Allergy Treatment Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global North America, Europe, and Australia Peanut Allergy Treatment Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of North America, Europe, and Australia Peanut Allergy Treatment involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the North America, Europe, and Australia Peanut Allergy Treatment Market:
The North America, Europe, and Australia Peanut Allergy Treatment Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for North America, Europe, and Australia Peanut Allergy Treatment Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study North America, Europe, and Australia Peanut Allergy Treatment Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, North America, Europe, and Australia Peanut Allergy Treatment market has been segmented into:
Epinephrine
Antihistamine
(Loratadine
Diphenhydramine
Others
By Application, North America, Europe, and Australia Peanut Allergy Treatment market has been segmented into:
Viaskin Peanut
Ligelizumab
CA002
PRT120
Dupilumab
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The North America, Europe, and Australia Peanut Allergy Treatment market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the North America, Europe, and Australia Peanut Allergy Treatment market.
Top Key Players Covered in North America, Europe, and Australia Peanut Allergy Treatment market are:
DBV Technologies
Aimmune Therapeutics
Inc.
Prota Therapeutics Pty Ltd.
COUR Pharmaceuticals
BlueWillow Biologics
HAL Allergy B.V.
Allergy Therapeutics PLC.
Novartis AG
Regeneron Pharmaceuticals
Inc.
Vedanta Biosciences
Inc.
Cambridge Allergy Ltd. (Camallergy)
Angany Inc.
Moonlight Therapeutics Inc.
Allero Therapeutics B.V.
Sanofi
Johnson & Johnson
Viatris Inc. (Mylan N.V.)
Sun Pharmaceutical Industries Ltd.
Bayer AG
Aurobindo Pharma Limited.
Astellas Pharma Inc.
Siolta Therapeutics
DESENTUM OY
ALK
Immunomic Therapeutics
Inc.
Stallergenes Greer Ltd.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: North America, Europe, and Australia Peanut Allergy Treatment Market by Type
4.1 North America, Europe, and Australia Peanut Allergy Treatment Market Snapshot and Growth Engine
4.2 North America, Europe, and Australia Peanut Allergy Treatment Market Overview
4.3 Epinephrine
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Epinephrine: Geographic Segmentation Analysis
4.4 Antihistamine
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Antihistamine: Geographic Segmentation Analysis
4.5 (Loratadine
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 (Loratadine: Geographic Segmentation Analysis
4.6 Diphenhydramine
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Diphenhydramine: Geographic Segmentation Analysis
4.7 Others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Others: Geographic Segmentation Analysis
Chapter 5: North America, Europe, and Australia Peanut Allergy Treatment Market by Application
5.1 North America, Europe, and Australia Peanut Allergy Treatment Market Snapshot and Growth Engine
5.2 North America, Europe, and Australia Peanut Allergy Treatment Market Overview
5.3 Viaskin Peanut
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Viaskin Peanut: Geographic Segmentation Analysis
5.4 Ligelizumab
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Ligelizumab: Geographic Segmentation Analysis
5.5 CA002
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 CA002: Geographic Segmentation Analysis
5.6 PRT120
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 PRT120: Geographic Segmentation Analysis
5.7 Dupilumab
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Dupilumab: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 North America, Europe, and Australia Peanut Allergy Treatment Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 DBV TECHNOLOGIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 AIMMUNE THERAPEUTICS
6.4 INC.
6.5 PROTA THERAPEUTICS PTY LTD.
6.6 COUR PHARMACEUTICALS
6.7 BLUEWILLOW BIOLOGICS
6.8 HAL ALLERGY B.V.
6.9 ALLERGY THERAPEUTICS PLC.
6.10 NOVARTIS AG
6.11 REGENERON PHARMACEUTICALS
6.12 INC.
6.13 VEDANTA BIOSCIENCES
6.14 INC.
6.15 CAMBRIDGE ALLERGY LTD. (CAMALLERGY)
6.16 ANGANY INC.
6.17 MOONLIGHT THERAPEUTICS INC.
6.18 ALLERO THERAPEUTICS B.V.
6.19 SANOFI
6.20 JOHNSON & JOHNSON
6.21 VIATRIS INC. (MYLAN N.V.)
6.22 SUN PHARMACEUTICAL INDUSTRIES LTD.
6.23 BAYER AG
6.24 AUROBINDO PHARMA LIMITED.
6.25 ASTELLAS PHARMA INC.
6.26 SIOLTA THERAPEUTICS
6.27 DESENTUM OY
6.28 ALK
6.29 IMMUNOMIC THERAPEUTICS
6.30 INC.
6.31 STALLERGENES GREER LTD.
Chapter 7: Global North America, Europe, and Australia Peanut Allergy Treatment Market By Region
7.1 Overview
7.2. North America North America, Europe, and Australia Peanut Allergy Treatment Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Epinephrine
7.2.4.2 Antihistamine
7.2.4.3 (Loratadine
7.2.4.4 Diphenhydramine
7.2.4.5 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Viaskin Peanut
7.2.5.2 Ligelizumab
7.2.5.3 CA002
7.2.5.4 PRT120
7.2.5.5 Dupilumab
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe North America, Europe, and Australia Peanut Allergy Treatment Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Epinephrine
7.3.4.2 Antihistamine
7.3.4.3 (Loratadine
7.3.4.4 Diphenhydramine
7.3.4.5 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Viaskin Peanut
7.3.5.2 Ligelizumab
7.3.5.3 CA002
7.3.5.4 PRT120
7.3.5.5 Dupilumab
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe North America, Europe, and Australia Peanut Allergy Treatment Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Epinephrine
7.4.4.2 Antihistamine
7.4.4.3 (Loratadine
7.4.4.4 Diphenhydramine
7.4.4.5 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Viaskin Peanut
7.4.5.2 Ligelizumab
7.4.5.3 CA002
7.4.5.4 PRT120
7.4.5.5 Dupilumab
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific North America, Europe, and Australia Peanut Allergy Treatment Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Epinephrine
7.5.4.2 Antihistamine
7.5.4.3 (Loratadine
7.5.4.4 Diphenhydramine
7.5.4.5 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Viaskin Peanut
7.5.5.2 Ligelizumab
7.5.5.3 CA002
7.5.5.4 PRT120
7.5.5.5 Dupilumab
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa North America, Europe, and Australia Peanut Allergy Treatment Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Epinephrine
7.6.4.2 Antihistamine
7.6.4.3 (Loratadine
7.6.4.4 Diphenhydramine
7.6.4.5 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Viaskin Peanut
7.6.5.2 Ligelizumab
7.6.5.3 CA002
7.6.5.4 PRT120
7.6.5.5 Dupilumab
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America North America, Europe, and Australia Peanut Allergy Treatment Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Epinephrine
7.7.4.2 Antihistamine
7.7.4.3 (Loratadine
7.7.4.4 Diphenhydramine
7.7.4.5 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Viaskin Peanut
7.7.5.2 Ligelizumab
7.7.5.3 CA002
7.7.5.4 PRT120
7.7.5.5 Dupilumab
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
North America, Europe, and Australia Peanut Allergy Treatment Scope:
|
Report Data
|
North America, Europe, and Australia Peanut Allergy Treatment Market
|
|
North America, Europe, and Australia Peanut Allergy Treatment Market Size in 2025
|
USD XX million
|
|
North America, Europe, and Australia Peanut Allergy Treatment CAGR 2025 - 2032
|
XX%
|
|
North America, Europe, and Australia Peanut Allergy Treatment Base Year
|
2024
|
|
North America, Europe, and Australia Peanut Allergy Treatment Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
DBV Technologies, Aimmune Therapeutics, Inc., Prota Therapeutics Pty Ltd., COUR Pharmaceuticals, BlueWillow Biologics, HAL Allergy B.V., Allergy Therapeutics PLC., Novartis AG, Regeneron Pharmaceuticals, Inc., Vedanta Biosciences, Inc., Cambridge Allergy Ltd. (Camallergy), Angany Inc., Moonlight Therapeutics Inc., Allero Therapeutics B.V., Sanofi, Johnson & Johnson, Viatris Inc. (Mylan N.V.), Sun Pharmaceutical Industries Ltd., Bayer AG, Aurobindo Pharma Limited., Astellas Pharma Inc., Siolta Therapeutics, DESENTUM OY, ALK, Immunomic Therapeutics, Inc., Stallergenes Greer Ltd..
|
|
Key Segments
|
By Type
Epinephrine
Antihistamine
(Loratadine
Diphenhydramine
Others
By Applications
Viaskin Peanut
Ligelizumab
CA002
PRT120
Dupilumab
|
